BD News

BD: BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new software application designed to help hospitals and health systems identify drug diversion at the 2018 American Society of Health-System Pharmacists (ASHP) Midyear Meeting

BD: BD Board Declares Dividends

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 cents per common share, an increase of 2.7 percent from the previous quarter.

BD: BD Donates 20 Million Syringes to Support Polio Eradication

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a donation of 20 million syringes valued at $1 million to Rotary, a nonprofit organization dedicated to tackling the world's most pressing humanitarian challenges, in support of the Global Polio Eradication Initiative.

BD: BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2018 earnings conference call on Tuesday, November 6, 2018, at 8:00 a.m.

BD: BD Statement on Divestiture of Advanced Bioprocessing Business

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the sale of its Advanced Bioprocessing business to Thermo Fisher Scientific

BD Announces Results for 2018 Third Fiscal Quarter; Raises Fiscal 2018 Revenue Guidance

BD Announces Results for 2018 Third Fiscal Quarter; Raises Fiscal 2018 Revenue Guidance

Metro Business Network